|
2013
|
Invention
|
Enterococcus antigens.
The present invention discloses isolated nucleic acid molecules encoding ... |
|
|
Invention
|
S. pneumoniae antigens.
The present invention discloses isolated nucleic acid molecules encoding... |
|
|
Invention
|
Vaccine composition comprising an antigen and a peptide having adjuvant properties.
The inventio... |
|
|
Invention
|
S. epidermidis antigens.
Hyperimmune serum reactive antigens and fragments thereof are disclosed... |
|
2012
|
Invention
|
Streptococcus pyogenes antigens.
The present invention discloses isolated nucleic acid molecules... |
|
|
Invention
|
Borrelia antigens.
The present invention relates to an isolated nucleic acid molecule encoding a... |
|
|
Invention
|
S. pneumoniae and compositions, methods and uses relating thereto. S. pneumoniae infection using ... |
|
|
Invention
|
S. epidermidis antigens. S. epidermidis infections, are disclosed. |
|
|
Invention
|
Borrelia antigens. Borrelia burgdorferi s.l. |
|
2011
|
Invention
|
Enterococcus antigens. E. faecalis, methods for isolating such antigens and specific uses thereof. |
|
|
Invention
|
Pharmaceutical composition comprising an antigen. The invention relates to immunogenic compositio... |
|
|
Invention
|
Hcv vaccines.
Disclosed are methods and compositions for inducing immune responses against Hepat... |
|
|
Invention
|
Ic31 nanoparticles. The invention discloses pharmaceutical compositions in liquid form comprising... |
|
2010
|
Invention
|
Hepatitis b virus specific human antibodies. The invention relates to binding agents, preferably ... |
|
|
Invention
|
Method for identification, isolation and production of antigens to a specific pathogen. Described... |
|
|
Invention
|
Moraxella catarrhalis antigens.
The present invention relates to isolated nucleic acid molecules... |
|
|
Invention
|
Moraxella catarrhalis antigens. The present invention relates to isolated nucleic acid molecules ... |
|
|
Invention
|
Hcv vaccines for chronic hcv patients.
The use of polycationic compounds for the preparation and... |
|
|
Invention
|
Nontypable haemophilus influenzae antigens. The present invention relates to isolated nucleic aci... |
|
|
Invention
|
Peptides protective against e. faecalis, methods and uses relating thereto.
The present inventio... |
|
|
Invention
|
Peptides protective against e. faecalis, methods and uses relating thereto. The present invention... |
|
2009
|
Invention
|
Streptococcus pyogenes antigens. S. pyogenes, methods for isolating such antigens and specific us... |
|
|
Invention
|
S. pneumoniae antigens. S. pneumoniae, methods for isolating such antigens and specific uses ther... |
|
|
Invention
|
Fully human influenza m2 specific antibodies. The present invention relates to human antibodies, ... |
|
|
Invention
|
Chlamydia pneumoniae antigens.
The present invention discloses isolated nucleic acid molecules e... |
|
|
Invention
|
bacterial polysaccharide-polypeptide conjugate compositions.
The present invention relates to i... |
|
|
Invention
|
Improved bacterial polysaccharide-polypeptide conjugate compositions. The present invention relat... |
|
|
Invention
|
Peptides protective against s. pneumoniae and compositions, methods and uses relating thereto. Th... |
|
|
Invention
|
Flaviviridae mutants comprising a deletion in the capsid protein for use as vaccines. The present... |
|
2008
|
Invention
|
Pharmaceutical composition comprising a japanese encephalitis virus for vaccination of patients o... |
|
|
Invention
|
Japanese encephalitis virus (jev) and tick-borne encephalitis virus (tbev) peptides stimulating h... |
|
|
Invention
|
Chlamydia antigens.
The present invention relates to isolated nucleic acid molecules which encod... |
|
|
Invention
|
Chlamydia antigens. The present invention relates to isolated nucleic acid molecules which encode... |
|
|
Invention
|
Method for isolating hepatitis c virus peptides.
Described are methods for isolating Hepatitis C... |
|
|
Invention
|
Klebsiella antigens. Klebsiella pneumoniae. |
|
|
Invention
|
Klebsiella antigens. The present invention relates to isolated nucleic acid molecules which encod... |
|
|
Invention
|
Protective proteins of s. agalactiae, combinations thereof and methods of using the same. The inv... |
|
2007
|
Invention
|
Method of vaccination comprising administering an antigen and a cathelicidin derived antimicrobia... |
|
|
Invention
|
Peptides protective against s. pneumoniae and compositions, methods and uses relating thereto.
T... |
|
|
Invention
|
Borrelia antigens. The present invention relates to isolated nucleic acid molecules which encode ... |
|
|
Invention
|
Small streptococcus pyogenes antigens and their use. The present invention relates to a peptide c... |
|
2006
|
Invention
|
Hcv vaccinations.
The invention relates to a method for preventing or treating Hepatitis C Virus... |
|
2005
|
Invention
|
Hcv vaccines for chronic hcv patients.
The invention discloses the use of polycationic compounds... |
|
|
Invention
|
Method for solubilizing peptide mixtures.
Described is a method for making a pharmaceutical prep... |
